INHIBIKASE THERAPEUTICS, INC.

IKT US45719W2052

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Annual Performance ¹

2021	2022	2023	2024	2025
-79%	-70%	-61%	144%	1%

Annual Insiders Turnover, USD ²

¹ annual and historical performance metrics are recalculated on a daily basis;
² represents the total value of insider transactions (both buying and selling);

Insider Activity

Person	Price	Shares	Total	Published	Completed
Bellini Roberto	1.37 USD	1,460,000 Bought	2,000,200 USD	21/10/2024	21/10/2024
Munshi Amit	1.37 USD	365,000 Bought	500,050 USD	21/10/2024	21/10/2024
Kush Arvind	1.37 USD	145,000 Bought	198,650 USD	21/10/2024	21/10/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include INHIBIKASE THERAPEUTICS, INC. to your watchlist and receive automatic alerts for upcoming transactions.

Generate

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

• Insider Transaction Amount Distribution
• Insider Trading Seasonality
• Delta Correlation Analysis

 

Historical Performance

1M	3M	6M	1Y	3Y	5Y	All Time
32%	135%	50%	-21%	0%	0%	-94%

Last	52W Low	52W High	All-Time Low	All-Time High	β
1.66	1.43	3.97	0.81	59.40

Company Insiders

Person / Entity	Transactions	Turnover, USD	Average, USD	First	Last
Bellini Roberto	1	2,000,200.00	2,000,200.00	21/10/2024	21/10/2024
Munshi Amit	1	500,050.00	500,050.00	21/10/2024	21/10/2024
Kush Arvind	1	198,650.00	198,650.00	21/10/2024	21/10/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies ³

Name	ISIN	Ticker
JATT ACQUISITION CORP	KYG9TY5A1016	ZURA

³ the firms where the current insiders have executed transactions.

Stock Advanced Metrics

Delta Correlation	subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4	subscribe 🔒

⁴ represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

⁵ a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.